BioMérieux researchers describe rise of multi-drug resistant Candida auris infections
Researchers at diagnostic company BioMérieux conducted a retrospective analysis of blood cultures positive for Candida auris (C. auris) and found an upsurge in the detection of this emerging fungal pathogen between 2021 and 2023. Read More
FDA approves Roche bispecific antibody for people with relapsed or refractory diffuse large B-cell lymphoma
The U.S. Food and Drug Administration (FDA) has approved Roche’s Columvi (glofitamab-gxbm), a bispecific antibody, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified after two or more lines of systemic therapy, the firm announced on Friday. Read More
Colorectal cancer growth and chemoresistance linked to protein in study
Researchers from Germany found that colorectal or bowel cancer grows faster and becomes more resistant to common forms of chemotherapy when elevated levels of a specific protein are present. Read More
Resistant leukemia treated with base-edited T cells
Three young patients with relapsed T-cell leukemia have now been treated with base-edited T cells, in an ongoing clinical trial collaboratively conducted by University College London (UCL) and Great Ormond Street Hospital for Children (GOSH). Read More
Reveal Genomics highlights results for breast cancer predictive test in phase II clinical trial
Precision oncology firm Reveal Genomics on Thursday announced that its HER2Dx genomic test for HER2+ breast cancer has been validated in the PHERGain phase II clinical trial. Read More
Gut bacteria changes in preclinical Alzheimer’s suggest ways to detect, delay disease
People with pre-symptomatic Alzheimer’s disease have different gut bacteria than healthy individuals, suggesting the microbiome could be used to detect or delay the condition. Read More
Gene discovered using DNA analysis may help prevent steroid-induced diabetes
Scientists from Australia’s Garvan Institute of Medical Research and Adelaide Medical School found that a gene called RELA, known to regulate inflammation, also plays an essential role in maintaining normal blood sugar levels. Read More
Chikungunya vaccine candidate in clinical trial found generally safe and effective
A study of U.S. adults found that a vaccine candidate for chikungunya disease was generally safe and well tolerated. Read More
Elevated lipoprotein(a) predicts recurrent heart disease in seniors
Increased blood levels of lipoprotein(a), a bad cholesterol variant, are a risk factor for recurrent coronary heart disease (CHD) in people over 60. Read More
NIH funds work to develop protocol for re-administration of DMD gene therapies
The National Institutes of Health (NIH) is funding work that could show how the immune system reacts to muscle disease gene therapies and lead to a protocol for re-administration of the treatments. Read More
Conferences
Science Briefs
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
